Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

被引：83

作者：

Peakman, Mark ^{[1
]}

von Herrath, Matthias ^{[2
]}

机构：

[1] Kings Coll London, Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr,Dept Immunobiol, London WC2R 2LS, England

[2] La Jolla Inst Allergy & Immunol, Ctr Type Diabet Res 1, La Jolla, CA USA

来源：

DIABETES | 2010年 / 59卷 / 09期

关键词：

ALTERED PEPTIDE LIGAND; EPITOPE-SPECIFIC IMMUNOTHERAPY; PHASE-II TRIAL; MULTIPLE-SCLEROSIS; IMMUNE DEVIATION; DENDRITIC CELLS; RHEUMATOID-ARTHRITIS; PERIPHERAL TOLERANCE; DOUBLE-BLIND; AMINO-ACIDS;

D O I：

10.2337/db10-0630

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：2087 / 2093

页数：7

相关论文

共 41 条

[1] Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B(9-23) epitope [J].

Alleva, DG ;

Maki, RA ;

Putnam, AL ;

Robinson, JM ;

Kipnes, MS ;

Dandona, P ;

Marks, JB ;

Simmons, DL ;

Greenbaum, CJ ;

Jimenez, RG ;

Conlon, PJ ;

Gottlieb, PA .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (01) :59-69

[2] ADA Outstanding Scientific Achievement Lecture 2004 - Thirty years of investigating the autointmune basis for type 1 diabetes - Why can't we prevent or reverse this disease? [J].

Atkinson, MA .

DIABETES, 2005, 54 (05) :1253-1263

[3] Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats [J].

Bellmann, K ;

Kolb, H ;

Rastegar, S ;

Jee, P ;

Scott, FW .

DIABETOLOGIA, 1998, 41 (07) :844-847

[4] Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].

Bielekova, B ;

Goodwin, B ;

Richert, N ;

Cortese, I ;

Kondo, T ;

Afshar, G ;

Gran, B ;

Eaton, J ;

Antel, J ;

Frank, JA ;

McFarland, HF ;

Martin, R .

NATURE MEDICINE, 2000, 6 (10) :1167-1175

[5] Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes [J].

Boissonnas, Alexandre ;

Scholer-Dahirel, Alix ;

Simon-Blancal, Virginie ;

Pace, Luigia ;

Valet, Fabien ;

Kissenpfennig, Adrien ;

Sparwasser, Tim ;

Malissen, Bernard ;

Fetler, Luc ;

Amigorena, Sebastian .

IMMUNITY, 2010, 32 (02) :266-278

[6] Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs [J].

Bresson, D ;

Togher, L ;

Rodrigo, E ;

Chen, YL ;

Bluestone, JA ;

Herold, KC ;

von Herrath, M .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1371-1381

[7] Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10 [J].

Burkhart, C ;

Liu, GY ;

Anderton, SM ;

Metzler, B ;

Wraith, DC .

INTERNATIONAL IMMUNOLOGY, 1999, 11 (10) :1625-1634

[8] Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression [J].

Campbell, John D. ;

Buckland, Karen F. ;

McMillan, Sarah J. ;

Kearley, Jennifer ;

Oldfield, William L. G. ;

Stern, Lawrence J. ;

Gronlund, Hans ;

van Hage, Marianne ;

Reynolds, Catherine J. ;

Boyton, Rosemary J. ;

Cobbold, Stephen P. ;

Kay, A. Barry ;

Altmann, Daniel M. ;

Lloyd, Clare M. ;

Larche, Mark .

JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (07) :1535-1547

[9] Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens [J].

CetkovicCvrlje, M ;

Gerling, IC ;

Muir, A ;

Atkinson, MA ;

Elliott, JF ;

Leiter, EH .

DIABETES, 1997, 46 (12) :1975-1982

[10] Peripheral tolerance in T cell receptor-transgenic mice: Evidence for T cell anergy [J].

Falb, D ;

Briner, TJ ;

Sunshine, GH ;

Bourque, CR ;

Luqman, M ;

Gefter, ML ;

Kamradt, T .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :130-135

← 1 2 3 4 5 →